Part 1: Evaluation of Pediatric Cannabis–Drug Interaction Reports

Abstract Data addressing safety concerns related to potential drug interactions between cannabis‐derived products and pharmaceutical medications in the pediatric population are lacking. In this study, we retrieved case reports through a published literature search using PubMed and spontaneous reporting data using the Food and Drug Administration’s Adverse Event Reporting System (FAERS) to identify potential cannabis– and cannabinoid–drug interactions in individuals younger than 18 years old. To evaluate the published case reports, we used the Drug Interaction Probability Scale (DIPS), a